Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68 NNS309

A radioconjugate composed of NNS309, which targets an as of yet unelucidated target on tumor cells, that is conjugated to the radionuclide gallium (Ga) 68, with potential use in diagnostic imaging using positron emission tomography/computed tomography (PET/CT). Upon administration of gallium Ga 68 NNS309, the NNS309 moiety targets and binds to tumor cells expressing the target. This allows the assessment of binding of NNS309 to tumor cells and the possible therapeutic response to NNS309 conjugated to a radionuclide delivering cytotoxic radiation, such as lutetium Lu 177 (Lu177).

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	[68Ga]-NNS309 68Ga-NNS309

gallium Ga 68 NNS309

Search NCI's Drug Dictionary